ABOUT US

ABOUT US

The ultimate solution for aortic diseases

The ultimate solution for aortic diseases

Aortyx is a pioneer company founded by researchers from the IQS School of Engineering and the Hospital Clínic de Barcelona that aims at providing a new generation of endovascular devices to treat vascular diseases. Our technology focuses on tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cell migration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta.

At Aortyx, we aim at delivering the ultimate solution for aortic diseases, tackling clear unmet needs, generating positive impact in our society with the most advanced available technology.

Aortyx is a pioneer company founded by researchers from the IQS School of Engineering and the Hospital Clínic de Barcelona that aims at providing a new generation of endovascular devices to treat vascular diseases. Our technology focuses on tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cell migration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta.

At Aortyx, we aim at delivering the ultimate solution for aortic diseases, tackling clear unmet needs, generating positive impact in our society with the most advanced available technology.

Mission

Mission

Aortyx’ mission is to deliver lifesaving solutions for patients suffering from aortic diseases. We want to provide cardiovascular surgeons and aortic disease patients with tools specifically designed to heal the aorta definitively and thus eliminate uncertainty, improving patient outcome when treating aortic diseases while reducing the associated costs.

Aortyx’ mission is to deliver lifesaving solutions for patients suffering from aortic diseases. We want to provide cardiovascular surgeons and aortic disease patients with tools specifically designed to heal the aorta definitively and thus eliminate uncertainty, improving patient outcome when treating aortic diseases while reducing the associated costs.

Values

Values

Excellence · Passion · Commitment · Honesty · Social Impact · Teamwork

Aortyx is committed to creating alternatives that generate true social impact in aortic diseases' patients. We listen to cardiovascular surgeons who demand innovative devices to develop excellent technology to deliver our solutions to citizenship. We disseminate our work honestly to raise awareness among the population and invite every stakeholder to play a relevant part in our venture.

Excellence · Passion · Commitment · Honesty · Social Impact · Teamwork

Aortyx is committed to creating alternatives that generate true social impact in aortic diseases' patients. We listen to cardiovascular surgeons who demand innovative devices to develop excellent technology to deliver our solutions to citizenship. We disseminate our work honestly to raise awareness among the population and invite every stakeholder to play a relevant part in our venture.

To date, we have been supported by FIPSE (2016 and 2018), the Catalan government through Llavor (2016) and Producte (2018), Fundació “la Caixa” through CaixaImpulse (2017). Most recently, we have received funding from EIT Health through Headstart (2019), Neotec CDTI (2019), Pyme Innovadora, Retos Colaboración 2019, the European Union’s Horizon 2020 research and innovation program under grant agreement H2020-SMEINST-876061_AORTYX.

To date, we have been supported by FIPSE (2016 and 2018), the Catalan government through Llavor (2016) and Producte (2018), Fundació “la Caixa” through CaixaImpulse (2017). Most recently, we have received funding from EIT Health through Headstart (2019), Neotec CDTI (2019), Pyme Innovadora, Retos Colaboración 2019, the European Union’s Horizon 2020 research and innovation program under grant agreement H2020-SMEINST-876061_AORTYX.